Investigation of human spleen dendritic cell phenotype and distribution reveals evidence of in vivo activation in a subset of organ donors

Blood

Volumn 97, Issue 11, 2001, Pages 3470-3477

  Mcllroy, Dorian ^a,b   Troadec, Christelle ^a,b   Grassi, Fernanda ^a,b   Samri, Assia ^a,b   Barrou, Benoît ^a,b   Autran, Brigitte ^a,b   Debré, Patrice ^a,b   Feuillard, Jean ^a,b   Hosmalin, Anne ^a,b,c  

^a PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^b AVICENNE HOSPITAL   (France)

^c INSERM   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CD11B ANTIGEN; CD14 ANTIGEN; CD16 ANTIGEN; CD19 ANTIGEN; CD3 ANTIGEN; CD86 ANTIGEN; HLA DR ANTIGEN;

ADULT; ANIMAL EXPERIMENT; ANTIGEN EXPRESSION; ARTICLE; B LYMPHOCYTE; BACTERIAL INFECTION; CELL ACTIVATION; CELL MATURATION; CLINICAL ARTICLE; DENDRITIC CELL; FEMALE; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE; MACROPHAGE; MALE; MOUSE; MULTIPLE TRAUMA; NONHUMAN; ORGAN DONOR; PHENOTYPE; PRIORITY JOURNAL; SPLEEN CELL; T LYMPHOCYTE;

EID: 0035383796     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.V97.11.3470     Document Type: Article

References (57)

1. Banchereau J, Steinman RM. Dendritic cells and the control of immunity. Nature. 1998;392:245-252.
2. Steinman R, Inaba K, Turley S, Pierre P, Mellman I. Antigen capture, processing, and presentation by dendritic cells: recent cell biological studies. Hum Immunol. 1999;60:562-567.
3. Reis e Sousa C, Sher A, Kaye P. The role of dendritic cells in the induction and regulation of immunity to microbial infection. Curr Opin Immunol. 1999;11:392-399.
4. Zinkernagel RM, Ehl S, Aichele P, Oehen S, Kündig T, Hengartner H. Antigen localization regulates immune responses in a dose- and time-dependent fashion: a geographical view of the immune response. Immunol Rev. 1997;156:199-209.
5. Sallusto F, Cella M, Danieli C, Lanzavecchia A. Dendritic cells use macropinocytosis and the mannose receptor to concentrate macromolecules in the major histocompatibility complex class II compartment: down-regulation by cytokines and bacterial products. J Exp Med. 1995;182:389-400.
6. Fanger NA, Voigtlaender D, Liu C, et al. Characterization of expression, cytokine regulation, and effector function of the high affinity IgG receptor FcγRI (CD64) expressed on human blood dendritic cells. J Immunol. 1997;158:3090-3098.
7. Sousa C, Stahl PD, Austyn JM. Phagocytosis of antigens by Langerhans cells in vitro. J Exp Med. 1993;178:509-519.
8. Avrameas A, Mcllroy D, Hosmalin A, et al. Expression of a mannose/fucose membrane lectin on human dendritic cells. Eur J Immunol. 1996;26:394-400.
9. + T lymphocytes by human blood dendritic cells in vitro. J Clin Invest. 1992;90:229-237.
10. Caux C, Vanbervliet B, Massacder C, Azuma M, Okumura K, Lanier LL. B70/B7-2 is identical to CD86 and is the major functional ligand for CD28 expressed on human dendritic cells. J Exp Med. 1994;180:1841-1847.
11. Inaba K, Witmer-Pack M, Inaba M, et al. The tissue distribution of the B7-2 costimulator in mice: abundant expression on dendritic cells in situ and during maturation in culture. J Exp Med. 1994;180:1849-1860.
12. Steinman RM, Witmer MD. Lymphoid dendritic cells are potent stimulators of the primary mixed lymphocyte reaction in mice. Proc Natl Acad Sci U S A. 1978;75:5132-5136.
13. Inaba K, Steinman RM, Voorhis WCV, Muramatsu S. Dendritic cells are critical accessory cells for thymus-dependent antibody responses in mouse and man. Proc Natl Acad Sci U S A. 1983;80:6041-6045.
14. Romani N, Koide S, Crowley M, et al. Presentation of exogenous protein antigens by dendritic cells to T cell clones: intact protein is presented best by immature, epidermal Langerhans cells. J Exp Med. 1989;169:1169-1178.
15. Sallusto F, Lanzavecchia A. Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and down-regulated by tumor necrosis factor alpha. J Exp Med. 1994;179:1109-1118.
16. Banchereau J, Brière F, Caux C, et al. Immunobiology of dendritic cells. Ann Rev Immunol. 2000;18:767-811.
17. Muraille E, Moser M. Staphylococcal enterotoxin B induces an early and transient state of immunosuppression characterized by V beta-unrestricted T cell unresponsiveness and defective antigen-presenting cell functions. J Immunol. 1997;158:2638-2647.
18. DeSmedt T, Pajak B, Muraille E, et al. Regulation of dendritic cell numbers and maturation by lipopolysaccharide in vivo. J Exp Med. 1996;184:1413-1424.
19. Reis e Sousa C, Hieny S, Scharton-Kersten T, et al. In vivo microbial stimulation induces rapid CD40L-independent production of IL-12 by dendritic cells and their re-distribution to T cell areas. J Exp Med. 1997;186:1819-1830.
20. Reis e Sousa C, Germain R. Analysis of adjuvant function by direct visualization of antigen presentation in vivo: endotoxin promotes accumulation of antigen-bearing dendritic cells in the T cell areas of lymphoid tissue. J Immunol. 1999;162:6552-6561.
21. Steinman RM, Pack M, Inaba K. Dendritic cells in the T-cell areas of lymphoid organs. Immunol Rev. 1997;156:25-37.
22. Metlay JP, Witmer-Pack MD, Agger R, Crowley MT, Lawless D, Steinman RM. The distinct leukocyte integrins of mouse spleen dendritic cells as identified with new hamster monoclonal antibodies. J Exp Med. 1990;171:1753-1771.
23. Kraal G, Breel M, Janse M, Bruin G. Langerhans cells, veiled cells, and interdigitating cells in the mouse recognized by a monoclonal antibody. J Exp Med. 1986;163:981-997.
24. Inaba K, Swiggard WJ, Inaba M, et al. Tissue distribution of the DEC-205 protein that is detected by the monoclonal antibody NLDC-145. Cell Immunol. 1995;163:148-156.
25. Vremec D, Zorbas M, Scollay R, et al. The surface phenotype of dendritic cells purified from mouse thymus and spleen: investigation of the CD8 expression by a subpopulation of dendritic cells. J Exp Med. 1992;176:47-58.
26. Agger R, Witmer-Pack M, Romani N, et al. Two populations of splenic dendritic cells detected with M342, a new monoclonal to an intracellular antigen of dendritic cells and some B lymphocytes. J Leukoc Biol. 1992;52:34-42.
27. Leenen PJM, Radosevic K, Voerman JSA, et al. Heterogeneity of mouse spleen dendritic cells: in vivo phagocytic activity, expression of macrophages markers, and subpopulation turnover. J Immunol. 1998;160:2166-2173.
28. Crowley M, Inaba K, Witmer-Pack M, Steinman RM. The cell surface of mouse dendritic cells: FACS analyses of dendritic cells from different tissues including thymus. Cell Immunol. 1989;118:108-125.
29. Buckley PJ. Phenotypic subpopulations of macrophages and dendritic cells in human spleen. Scanning Microsc. 1991;5:147-158.
30. Zhou LJ, Schwarting R, Smith HM, Tedder TF. A novel cell-surface molecule expressed by human interdigitating reticulum cells, Langerhans cells, and activated lymphocytes is a new member of the Ig superfamily. J Immunol. 1992;149:735-742.
31. Grouard G, Durand I, Filgueira L, Banchereau J, Liu Y-J. Dendritic cells capable of stimulating T-cells in germinal centres. Nature. 1996;384:364-367.
32. Winkel K, Sotzik F, Vremec D, Cameron PU, Shortman K. CD4 and CD8 expression by human and mouse thymic dendritic cells. Immunol Lett. 1994;40:93-99.
33. + T lymphocyte infection frequency in spleens of HIV-positive patients. J Virol. 1995;69:4737-4745.
34. Heufler C, Koch F, Stanzl U, et al. Interleukin-12 is produced by dendritic cells and mediates T helper 1 development as well as interferon-γ production by T helper 1 cells. Eur J Immunol. 1996;26:659-668.
35. McIlroy D, Autran B, Clauvel J-P, Oksenhendler E, Debré P, Hosmalin A. Low CD83, but normal MHC class II and costimulatory molecule expression, on spleen dendritic cells from HIV+ patients. AIDS Res Hum Retroviruses. 1998;14:505-513.
36. O'Doherty U, Peng M, Gezelter S, et al. Human blood contains two subsets of dendritic cells, one immunologically mature and the other immature. Immunology. 1994;82:487-493.
37. Olweus J, BitMansour A, Warnke R et al. Dendritic cell ontogeny: a human dendritic cell lineage of myeloid ontogeny. Proc Natl Acad Sci U S A. 1997;94:12551-12556.
38. Rissoan MC, Soumelis V, Kadowaki N, et al. Reciprocal control of T helper cell and dendritic cell differentiation. Science. 1999;283:1183-1186.
39. Cella M, Jarrossay D, Facchetti F, et al. Plasmacytoid monocytes migrate to inflamed lymph nodes and produce large amounts of type I interferon. Nat Med. 1999;5:919-924.
40. Grassi FR, Hosmalin A, McIlroy D, Calvez V, Debré P, Autran B. CD11c-positive dendritic cells are depleted in the blood of HIV-infected patients. AIDS. 1999;13:759-766.
41. Brocker T, Riedinger M, Karjalainen K. Targeted expression of major histocompatibiiity complex (MHC) class II molecules demonstrates that dendritic cells can induce negative but not positive selection of thymocytes in vivo. J Exp Med. 1997;185:541-550.
42. McLellan AD, Starling GC, Williams LA, Hock BD, Hart DNJ. Activation of human peripheral blood dendritic cells induces the CD86 co-stimulatory molecule. Eur J Immunol. 1995;25:2064-2068.
43. Roake JA, Rao AS, Morris PJ, Larsen CP, Hankins DF, Austyn JM. Dendritic cells loss from nonlymphoid tissues after systemic administration of lipopolysaccharide, tumor necrosis factor, and interleukin 1. J Exp Med. 1995;181:2237-2247.
44. McPherson G, Jenkins C, Stein M, Edwards C. Endotoxin-mediated dendritic cell release from the intestine: characterization of released dendritic cells and TNF dependence. J Immunol. 1995;154:1317-1322.
45. Hirschl MM, Gwechenberger M, Binder T, et al. Assessment of myocardial injury by serum tumour necrosis factor alpha measurements in acute myocardial infarction. Eur Heart J. 1996;17:1852-1859.
46. Wood GS, Turner RR, Shiurba RA, Eng L, Warnke RA. Human dendritic cells and macrophages: in situ immunophenotypic definition of subsets that exhibit specific morphologic and microenvironmental characteristics. Am J Pathol. 1985;119:73-82.
47. Siegal F, Kadowaki N, Shodell M, et al. The nature of the principal type 1 interferon-producing cells in human blood. Science. 1999;284:1835-1837.
48. Grouard G, Rissoan M-C, Filgueira L, Durand I, Banchereau J, Liu Y-J. The enigmatic plasmacytoid T cells develop into dendritic cells with Interleukin 3 and CD40-ligand. J Exp Med. 1997;185:1101-1111.
49. Inaba K, Mellay JP, Crowley MT, Steinman RM. Dendritic cells pulsed with protein antigens in vitro can prime antigen-specific, MHC restricted T cells in situ. J Exp Med. 1990;172:631-640.
50. Witmer-Pack M, Crowley M, Inaba K, Steinman R. Macrophages, but not dendritic cells, accumulate colloid carbon following administration in situ. J Cell Sci. 1993;105:965-973.
51. Verhasselt V, Buelens C, Willems F, et al. Bacterial lipopolysacchadde stimulates the production of cytokines and the expression of costimulatory molecules by human peripheral blood dendritic cells: evidence for a soluble CD14-dependent pathway. J Immunol. 1997;158:2919-2925.
52. Larsen CP, Morris PJ, Austyn JM. Migration of dendritic leukocytes from cardiac allografts into host spleens: a novel pathway for the initiation of rejection. J Exp Med. 1990;171:307-314.
53. Oral H, Kapadia S, Nakano M, et al. Tumor necrosis factor-alpha and the failing human heart. Clin Cardiol. 1995;18(suppl 4):20-27.
54. Testa M, Yeh M, Lee P, et al. Circulating levels of cytokines and their endogenous modulators in patients with mild to severe congestive heart failure due to coronary artery disease or hypertension. J Am Coll Cardiol. 1996;28:964-971.
55. Reis e Sousa C, Yap G, Schulz O, et al. Paralysis of dendritic cell IL-12 production by microbial products prevents infection-induced immunopathology. Immunity. 1999;11:637-647.
56. Starzl T. The art of tolerance. Nat Med. 1998;4: 1006-1007.
57. Qian S, Lu L, Fu F, et al. Donor pretreatment with Flt-3 ligand augments antidonor cytotoxic T lymphocyte, natural killer, and lymphokine-activated killer cell activities within liver allografts and alters the pattern of intragraft apoptotic activity. Transplantation. 1998;65:1590-1598.